DK255190A - Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader - Google Patents

Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader Download PDF

Info

Publication number
DK255190A
DK255190A DK255190A DK255190A DK255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A
Authority
DK
Denmark
Prior art keywords
certain
procedures
paf antagonist
combinations
antihistamine
Prior art date
Application number
DK255190A
Other languages
English (en)
Other versions
DK255190D0 (da
Inventor
M Motasim Billah
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK255190D0 publication Critical patent/DK255190D0/da
Publication of DK255190A publication Critical patent/DK255190A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK255190A 1988-04-27 1990-10-23 Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader DK255190A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27
PCT/US1989/001671 WO1989010143A1 (en) 1988-04-27 1989-04-24 Certain paf antagonist antihistamine combinations and methods

Publications (2)

Publication Number Publication Date
DK255190D0 DK255190D0 (da) 1990-10-23
DK255190A true DK255190A (da) 1990-10-23

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK255190A DK255190A (da) 1988-04-27 1990-10-23 Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader

Country Status (15)

Country Link
EP (2) EP0345931B1 (da)
JP (1) JPH0655673B2 (da)
KR (1) KR930009786B1 (da)
AT (1) ATE84724T1 (da)
AU (1) AU619555B2 (da)
CA (1) CA1327316C (da)
DE (1) DE68904475T2 (da)
DK (1) DK255190A (da)
ES (1) ES2044100T4 (da)
IE (1) IE63697B1 (da)
IL (1) IL90100A (da)
MY (1) MY106956A (da)
NZ (1) NZ228879A (da)
WO (1) WO1989010143A1 (da)
ZA (1) ZA893101B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
EP0469477B1 (en) * 1990-08-02 1995-09-20 F. Hoffmann-La Roche Ag Antiallergic combination
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
NZ228879A (en) 1992-08-26
AU3578289A (en) 1989-11-24
MY106956A (en) 1995-08-30
EP0345931A1 (en) 1989-12-13
ATE84724T1 (de) 1993-02-15
ZA893101B (en) 1989-12-27
IE891362L (en) 1989-10-27
ES2044100T4 (es) 1996-07-16
DE68904475D1 (de) 1993-03-04
EP0402422A1 (en) 1990-12-19
EP0345931B1 (en) 1993-01-20
JPH0655673B2 (ja) 1994-07-27
CA1327316C (en) 1994-03-01
DK255190D0 (da) 1990-10-23
IL90100A0 (en) 1989-12-15
IE63697B1 (en) 1995-05-31
DE68904475T2 (de) 1993-05-13
WO1989010143A1 (en) 1989-11-02
ES2044100T3 (es) 1994-01-01
JPH03502097A (ja) 1991-05-16
KR900700136A (ko) 1990-08-11
KR930009786B1 (ko) 1993-10-11
AU619555B2 (en) 1992-01-30
IL90100A (en) 1995-01-24

Similar Documents

Publication Publication Date Title
DE3885816D1 (de) Mischungen von Polycarbonat und von Siloxan-Polyetherimid-Copolymer.
FI882791A7 (fi) Aineita, jotka parantavat määrättyjen 1,4-dihydropyridiinijohdannaisten siirtymistä ihon läpi.
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
DE69402330D1 (de) Analgetisches mittel und dessen verwendung
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
FI915970A7 (fi) Lääkkeitä, jotka ovat hyödyllisiä syövän hoidossa ja joilla on antihis tamiiniominaisuuksia
DE3866038D1 (de) Bohrer und zugehoeriger schneideinsatz.
DK255190A (da) Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader
DE68906345D1 (de) Antimalariazusammenstellungen, gebrauchmachend von quinidin, artemisinin und ihren derivaten.
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DK0669394T3 (da) Bifunktionelle urokinasevarianter med forbedrede fibrinolytiske egenskaber og thrombinhæmmende virkninger
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DE68914711D1 (de) 1,4-Disubstituierte-2,3,4,6-tetrahydroxy-1,4-diphosphorinan und ihre Oxide oder Sulfides.
NO894532D0 (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
FI883943A0 (fi) Modifierade plasminogen-aktivatorer.
NO881965D0 (no) Tilsetningsmiddel for borevaesker, fremstilling og anvendelse.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE68919593D1 (de) Verwendung von Zofenopril zur Herstellung von Medikamenten gegen rheumatoide Arthritis.
FI896159A0 (fi) Valsanordning med en undervals med hydrauliskt innerstoed.
DK24889D0 (da) Tetrahydropyridin-derivater
FI883268A0 (fi) Engaongssugpaose foer patientsekret.
FR2654242B1 (fr) Jeu educatif.
ATE88893T1 (de) Antimalariazusammenstellungen, gebrauchmachend von quinidin, artemisinin und ihren derivaten.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment